Category: Diagnostic Technologies

Diagnostic Technologies

CAP is improving global healthcare by partnering with hospitals and laboratories in developing countries to enhance diagnostic quality.

Precision oncology is undergoing rapid transformation driven by NGS technology, but systemic barriers in testing access must be overcome.

Next-generation AI-powered digital pathology platforms are revolutionizing wet mount slide handling, improving efficiency and accuracy.

AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform.

UC Irvine scientists have developed a tool called Phollow that allows real-time tracking of phages in the gut microbiome.

Advanced Instruments' freezing point osmometer aims to streamline osmolality testing workflows with automation and enhanced efficiency.

A new diagnostic classification module for AHEAD Medicine's Cyto-Copilot platform enhances AML versus non-neoplastic classification.

Babson Diagnostics has expanded its BetterWay blood testing menu to 61 tests, including key thyroid, kidney & cardiovascular health markers.

Diasorin has received FDA 510(k) clearance for its LIAISON PLEX Gram-Positive Blood Culture Assay, completing its syndromic blood culture portfolio.

Thermo Fisher Scientific unveiled advanced mass spectrometry instruments—Orbitrap Astral Zoom MS and Orbitrap Excedion Pro MS.

Avails Medical's electrical AST system provides same-day antibiotic susceptibility test results directly from positive blood cultures.

Rutgers and Yale engineers have developed a portable device that rapidly detects rare genetic mutations from a single drop of blood.

Researchers have developed a new bioluminescence-based diagnostic tool that offers virus detection in complex biological samples.

Vibrant Wellness has launched the Hormone Zoomer, a urine test providing analysis of hormone metabolism, endocrine disruptors, etc.